Literature DB >> 3040453

Influence of cytomegalovirus infection on the recovery of humoral immunity after autologous bone marrow transplantation.

L F Verdonck, J A van der Linden, B J Bast, F H Gmelig Meyling, G C de Gast.   

Abstract

Recovery of B-cell number and function was studied in 23 patients with hematological malignancies treated with high-dose chemoradiotherapy followed by autologous bone marrow transplantation (auto-BMT) in relation to the presence or absence of cytomegalovirus (CMV) infection. B cells recovered rapidly after auto-BMT and specific antibodies to herpes viruses remained nearly unchanged. Both were independent of the CMV status of the patients. However, the capacity of peripheral blood B cells to differentiate in vitro into cytoplasmic immunoglobulin (Ig)-positive cells (plasma cells) on pokeweed mitogen stimulation in the presence of normal T-cell help was significantly better in CMV-negative patients than in CMV-positive patients after auto-BMT, but was decreased in both groups. Serum Ig levels were, in contrast, higher in CMV-positive patients than in CMV-negative patients after auto-BMT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040453

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

Review 1.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

2.  Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.

Authors:  G J Boland; A M Vlieger; C Ververs; G C De Gast
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

3.  Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.

Authors:  Senthilnathan Palaniyandi; Sabarinath Venniyil Radhakrishnan; Fridrik J Karlsson; Karen Y Stokes; Nicolai Kittan; Elisabeth Huber; Gerhard C Hildebrandt
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.